Digest Network Come funziona
Network
/
Società
Sa
Non verificato

Savara Inc.

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaMedicina - VarieSalute

66 comunicati stampa

Guarda tutti i comunicati
04/02/2026
Biotecnologia
Farmaceutica
Salute
Eventi
Web e Social Network
Savara Announces Participation in Upcoming Investor Healthcare Conferences
Fonte
Savara Inc.
Emittente
Business Wire
1.00
0
27/01/2026
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
Mercato del lavoro
Industria
Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*
Fonte
Savara Inc.
Emittente
Business Wire
1.00
0
16/01/2026
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Medicina - Varie
Mercato azionario
Finanza
Savara Announces New Employment Inducement Grant
Fonte
Savara Inc.
Emittente
Business Wire
1.00
0
08/01/2026
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Mercato del lavoro
Industria
PANTHERx® Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI*
Fonte
Savara Inc.
Emittente
Business Wire
1.00
0
22/12/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Attrezzature medico-sanitarie
Medicina - Varie
Industria
Savara Resubmits the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
Fonte
Savara Inc.
Emittente
Business Wire
1.00
0
17/12/2025
Eventi
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Savara Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Fonte
Savara Inc.
Emittente
Business Wire
1.00
0
11/12/2025
Industria
Biotecnologia
Attrezzature medico-sanitarie
Salute
Farmaceutica
Medicina - Varie
Savara Announces European Patent Office (EPO) Intends to Grant a Patent for the Liquid Formulation of MOLBREEVI*
Fonte
Savara Inc.
Emittente
Business Wire
1.00
0
02/12/2025
Biotecnologia
Attrezzature medico-sanitarie
Salute
Farmaceutica
Medicina - Varie
Industria
Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System
Fonte
Savara Inc.
Emittente
Business Wire
1.00
0
20/11/2025
Biotecnologia
Farmaceutica
Salute
Eventi
Web e Social Network
Savara Announces Participation in Upcoming Investor Healthcare Conferences
Fonte
Savara Inc.
Emittente
Business Wire
1.00
0
12/11/2025
Biotecnologia
Sanità
Farmaceutica
Salute
Mercato azionario
Savara Reports Third Quarter 2025 Financial Results and Provides Business Update
Fonte
Savara Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0